Recurrent Disease Active Not Recruiting Phase 2 Trials for Imatinib (DB00619)

DBCOND0028541 (Recurrent Disease)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT00036738Fludarabine Phosphate and Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate, Dasatinib, or NilotinibTreatment